Keywords: b-m, squibb, sets, taxol, price, bristol-myers, revealed
B-M SQUIBB SETS US TAXOL PRICE
Article | 18 January 1993
Bristol-Myers Squibb has revealed that a two-to-six month course of treatment with its recently-approved Taxol (paclitaxel) will cost US private-sector ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
